Literature DB >> 23458503

A role for Sv2c in basal ganglia functions.

D Dardou1, S Monlezun, P Foerch, J P Courade, L Cuvelier, M De Ryck, S N Schiffmann.   

Abstract

SV2C is an isoform of the synaptic vesicle 2 protein family that exhibits a particular pattern of brain expression with enriched expression in several basal ganglia nuclei. In the present study, we have investigated SV2C implication in both normal and pathological basal ganglia functioning with a peculiar attention to dopamine neuron containing regions. In SV2C-/- mice, the expression of tyrosine hydroxylase mRNA in midbrain dopaminergic neurons was largely and significantly increased and enkephalin mRNA expression was significantly decreased in the caudate-putamen and accumbens nucleus. The expression of SV2C was studied in two models of dopaminergic denervation (6-OHDA- and MPTP-induced lesions). In dopamine-depleted animals, SV2C mRNA expression was significant increased in the striatum. In order to further understand the role of SV2C, we performed behavioral experiments on SV2C-/- mice and on knock-down mice receiving an injection of adeno-associated virus expressing SV2C miRNA specifically in the ventral midbrain. These modifications of SV2C expression had little or no impact on behavior in open field and elevated plus maze. However, even if complete loss of SV2C had no impact on conditioned place preference induced by cocaine, the specific knock-down of SV2C expression in the dopaminergic neurons completely abolished the development of a CPP while the reaction to an acute drug injection remains similar in these mice compared to control mice. These results showed that SV2C, a poorly functionally characterized protein is strongly involved in normal operation of the basal ganglia network and could be also involved in system adaptation in basal ganglia pathological conditions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458503     DOI: 10.1016/j.brainres.2013.02.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.

Authors:  Timothy L Ramsey; Qian Liu; Bill W Massey; Mark D Brennan
Journal:  Schizophr Res       Date:  2013-07-23       Impact factor: 4.939

2.  Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain.

Authors:  Amy R Dunn; Carlie A Hoffman; Kristen A Stout; Minagi Ozawa; Rohan K Dhamsania; Gary W Miller
Journal:  Brain Res       Date:  2017-12-21       Impact factor: 3.252

Review 3.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

4.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

5.  Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.

Authors:  Jia Nee Foo; Elaine Guo Yan Chew; Sun Ju Chung; Rong Peng; Cornelis Blauwendraat; Mike A Nalls; Kin Y Mok; Wataru Satake; Tatsushi Toda; Yinxia Chao; Louis C S Tan; Moses Tandiono; Michelle M Lian; Ebonne Y Ng; Kumar-M Prakash; Wing-Lok Au; Wee-Yang Meah; Shi Qi Mok; Azlina Ahmad Annuar; Anne Y Y Chan; Ling Chen; Yongping Chen; Beom S Jeon; Lulu Jiang; Jia Lun Lim; Juei-Jueng Lin; Chunfeng Liu; Chengjie Mao; Vincent Mok; Zhong Pei; Hui-Fang Shang; Chang-He Shi; Kyuyoung Song; Ai Huey Tan; Yih-Ru Wu; Yu-Ming Xu; Renshi Xu; Yaping Yan; Jing Yang; BaoRong Zhang; Woon-Puay Koh; Shen-Yang Lim; Chiea Chuen Khor; Jianjun Liu; Eng-King Tan
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

Review 6.  Puzzling Out Synaptic Vesicle 2 Family Members Functions.

Authors:  Odile Bartholome; Priscilla Van den Ackerveken; Judit Sánchez Gil; Orianne de la Brassinne Bonardeaux; Pierre Leprince; Rachelle Franzen; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2017-05-22       Impact factor: 5.639

7.  Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.

Authors:  Amy R Dunn; Kristen A Stout; Minagi Ozawa; Kelly M Lohr; Carlie A Hoffman; Alison I Bernstein; Yingjie Li; Minzheng Wang; Carmelo Sgobio; Namratha Sastry; Huaibin Cai; W Michael Caudle; Gary W Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-28       Impact factor: 11.205

Review 8.  Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.

Authors:  Wolfgang Löscher; Michel Gillard; Zara A Sands; Rafal M Kaminski; Henrik Klitgaard
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

9.  Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice.

Authors:  Kristen A Stout; Amy R Dunn; Kelly M Lohr; Shawn P Alter; Rachel A Cliburn; Thomas S Guillot; Gary W Miller
Journal:  ACS Chem Neurosci       Date:  2016-08-18       Impact factor: 4.418

10.  Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats.

Authors:  Veronica Antipova; Andreas Wree; Carsten Holzmann; Teresa Mann; Nicola Palomero-Gallagher; Karl Zilles; Oliver Schmitt; Alexander Hawlitschka
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.